Publications « DELIVER-MS - does early treatment with highly effective DMT improve the prognosis for people with Multiple Sclerosis?

1. “Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis,” from The Lancet Neurology. Click here to read the full article.

2. “Achieving effective patient and public involvement in international clinical trials in neurology,” from Neurology: Clinical Practice. Click here to read the full article.

REMOTE Sub-Study

New DELIVER-MS Sub-study ‘REMOTE’ (Remote Evaluation of Multiple sclerosis Outcomes Through Evaluation: a feasibility study) is enrolling the initial participants from the DELIVER-MS cohort....

DELIVER-MS Webinar

We held a public Webinar to provide an update on the study progress. This was held on July 7, 2025 at UK: 3-4pm US:...

DELIVER Highlighted in Neurology Podcast

DELIVER-MS work highlighted with a Neurology podcast and editorial titled Making public and patient involvement in clinical trials more than aspirational (https://cp.neurology.org/content/10/3/188). This commentary...